Overview

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

Status:
Completed
Trial end date:
1997-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
New York MDRU
Treatments:
Buprenorphine
Buprenorphine, Naloxone Drug Combination
Naloxone